je.st
news
Tag: fda
FDA Rethinks OTC
2014-02-21 15:40:00| Happi Breaking News
The system isn't working, says Woodcock
Tags: fda
otc
rethinks
fda otc
FDA Accepts for Review Mercks Biologics License Application for V503, Investigational 9-valent Human Papillomavirus Vaccine
2014-02-20 14:30:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the Biologics License Application for V503, its investigational 9-valent human papillomavirus (HPV) vaccine, has been accepted for standard review by the U.S. Food and Drug Administration. About Merck Language: English Contact: MerckMedia Contacts:Pamela Eisele, 267-305-3558Imraan Munshi, 215-652-0059orInvestor Contacts:Carol Ferguson, 908-423-4465Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: review
application
human
license
FDA rejects wider use of Xarelto drug
2014-02-15 15:47:31| Biotech - Topix.net
U.S. health regulators have again declined to approve proposed wider uses of Bayer AG and Johnson & Johnson's lucrative blood clot preventer Xarelto, the drugmakers said on Friday.
FDA Rejects Wider Use Of J&J Xarelto For Third Time
2014-02-14 20:44:25| Food - Topix.net
Johnson & Johnson said Friday that the Food and Drug Administration has rejected - for a third time - its application to expand use of the blood thinner Xarelto to reduce dangerous blood clots and related problems in patients with coronary artery disease.
UPDATE 2-U.S. FDA rejects wider use of Xarelto drug
2014-02-14 20:22:38| Chemicals - Topix.net
U.S. health regulators have again declined to approve proposed wider uses of Bayer AG and Johnson & Johnson's lucrative blood clot preventer Xarelto, the drugmakers said on Friday.
Sites : [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] next »